V-Bio Ventures is a European venture capital firm focused on life sciences investments. They target start-up and early-stage companies with high growth potential, primarily in healthcare and sustainable agriculture. The firm invests throughout Europe, seeking technologies that offer transformational improvements in their respective fields.
V-Bio Ventures aims to contribute more than just capital, leveraging their extensive network and sector expertise to help transform scientific innovation into impactful products. Notable portfolio companies include Confo Therapeutics and Orionis Biosciences. The firm's approach involves becoming deeply involved with their portfolio companies, striving to be "part of the DNA" of new ventures they support.
V-Bio Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Follow-on Investments3
Current Portfolio Count2
Top Investment Stages
Series A2 (40.0%)
Series B2 (40.0%)
Series C1 (20.0%)
Stage Mix
Series A 40%Series B 40%Series C 20%
Concentration shown as share of disclosed investments by stage.
V-Bio Ventures - Classification
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
